Delavirdine gets FDA approval. Food and Drug Administration.
D020008:Delavirdine; D017277:Drug Approval; D016527:Drug Costs; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D007211:Indoles / Q000191:economics / Q000627:therapeutic use*; D010879:Piperazines / Q000191:economics / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D007211:Indoles; D010879:Piperazines; D018894:Reverse Transcriptase Inhibitors; D019469:Indinavir; D020008:Delavirdine